Highlights from PSA: Will Investors Rise Over Reimbursement Hurdles?
This article was originally published in Start Up
Executive Summary
At our September 2009 Pharmaceutical Strategic Alliances meeting, a recurring theme concerned the growing importance of factoring reimbursement hurdles into drug development decisions. Where does that start? In some cases, at Series A.